The study, conducted in mice, opens a path for exploring treatments that combine epigenetic approaches with therapies that use the body’s natural immune response.
Research brief: UCLA researchers found that chemotherapy is often underutilized when treating adults with sarcoma, a rare type of cancer of the soft tissues or bone.